ProForma 2.0
Not calculated for this record
DCMAC-OT
Aliases: DCANBP-OT, DCMAC-OT, Me6I2-BODIPY-OT, oxytocin
Normalized sequence
CYIQNCPLG
9 amino acids
Release PepDiana-V1-20260620
20
Activity records
1
Source papers
12
Positive
8
Negative / threshold
Cross-layer links
Versioned scientific descriptors
No separate physicochemical property was reported in the primary-literature identity record. PepDiana release values are shown as computed properties.
Molecular weight
Not calculated
Molecular formula
Not calculated
Theoretical pI
Not calculated
Net charge at pH 7
Not calculated
GRAVY
Not calculated
Instability index
Not calculated
Aromaticity
Not calculated
Topological polar surface area
Not calculated
cLogP
Not calculated
Hydrogen-bond donors
Not calculated
Hydrogen-bond acceptors
Not calculated
Rotatable bonds
Not calculated
Method: Not recorded
Tool: Not recorded
Calculated: Not recorded
ProForma 2.0
Not calculated for this record
HELM 2.0
Not calculated for this record
Canonical SMILES
Not calculated for this record
Isomeric SMILES
Not calculated for this record
Paper-level observations
Figure 5A; Table S2. OT positive control on hOTR.
Figure 5A; Table S2. DCMAC-OT 1 on hOTR. Text: '150 → >3900-fold higher EC50 values than parent peptides'.
Figure 5A; Table S2. DCANBP-OT 3 on hOTR. Text: '>2,100-3,900-fold higher EC50 values compared to parent peptides'.
Figure 5A; Table S2. Me6I2-BODIPY-OT 5 on hOTR. Text: '3- to 9-fold rightward shift in EC50 compared to OT'.
Figure 5D; Table S3. DCMAC-OT 1* on hOTR. Text: '75-fold increase in potency for hOTR'.
Figure 5D; Table S3. DCANBP-OT 3* on hOTR. Text: '400-fold increase in activity'.
Figure 5D; Table S3. Me6I2-BODIPY-OT 5* on hOTR. Text: 'only a minor increase in activity (~2-fold)'.
Figure 5F. DCMAC-OT 1 at 100 nM on hV1aR. Text: 'most caged photoprobes exhibited no activity at 100 nM'.
Figure 5F. DCMAC-OT 1 at 100 nM on hV1bR. Text: 'most caged photoprobes exhibited no activity at 100 nM'.
Figure 5F. DCANBP-OT 3 at 100 nM on hV1aR. Text: 'most caged photoprobes exhibited no activity at 100 nM'.
Figure 5F. DCANBP-OT 3 at 100 nM on hV1bR. Text: 'most caged photoprobes exhibited no activity at 100 nM'.
Figure 5F. Me6I2-BODIPY-OT 5 at 100 nM on hV1aR. Text: 'most caged photoprobes exhibited no activity at 100 nM'.
Figure 5F. Me6I2-BODIPY-OT 5 at 100 nM on hV1bR. Text: 'most caged photoprobes exhibited no activity at 100 nM'.
Figure 4. OT positive control in MTT assay. Text: 'OT itself reduced cell viability over 48 h'.
Figure 4. DCMAC-OT 1 in MTT assay. Text: 'Most photocaged OT probes ... exhibited higher cell viability than unmodified OT'.
Figure 4. DCMAC-OT 1* in MTT assay. Text: 'The uncaged compound mixtures exhibited values comparable to those of OT'.
Figure 4. DCANBP-OT 3 in MTT assay. Text: 'Most photocaged OT probes ... exhibited higher cell viability than unmodified OT'.
Figure 4. DCANBP-OT 3* in MTT assay. Text: 'The uncaged compound mixtures exhibited values comparable to those of OT'.
Figure 4. Me6I2-BODIPY-OT 5 in MTT assay. Text: 'except for 1 uM 5' exhibited higher cell viability than unmodified OT.
Figure 4. Me6I2-BODIPY-OT 5* in MTT assay. Text: 'The uncaged compound mixtures exhibited values comparable to those of OT'.
Citation and release provenance
Cite this identity as PepDiana record PEPDIA-PLP-003437, release PepDiana-V1-20260620. Experimental observations retain their paper, mention, and activity-record identifiers.
Record updated: 2026-06-22T07:14:26.229247+00:00